Maze Therapeutics annual operating margin
2024
Maze Therapeutics Operating Margin Growth & History (MAZE)
Maze Therapeutics's operating margin was 34.38% for fiscal 2024.
View full Maze Therapeutics company overviewMaze Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | 34.38% | — |
Maze Therapeutics quarterly operating margin
Q2.24
Q3.24
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −132.77% | — |
| Q3 2024 | 2024-09-30 | −969.16% | — |
| Q2 2024 | 2024-06-30 | 84.58% | — |
Maze Therapeutics operating margin trends
The latest reported quarter, Q1 2026, shows −132.77%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maze Therapeutics source filings ↗